Bluebird, Regeneron Team Up To Make Cell Therapies For Cancer

Aug 6, 2018, 08:13 AM by Michael Croft

Xconomy | Regeneron and Bluebird have struck a wide-ranging deal to broaden the reach of their respective cancer immunotherapy work, inking a deal to develop multiple cell therapies together.

August 06, 2018 | Regeneron and Bluebird have struck a wide-ranging deal to broaden the reach of their respective cancer immunotherapy work, inking a deal to develop multiple cell therapies together. Xconomy